The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...
Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...
Exicure, Inc. (Nasdaq: XCUR, the “Company”) releases the following financial results for the year ended December 31, 2025. 2025 Financial Results Cash Position: Cash and cash equivalents were $3.7 ...
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic ...
Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ...
Life on Earth may have origins from far, far away. Scientists have found a full set of life-building molecules in a nearly ...
In nature, a certain size is often a prerequisite for biomolecules to perform their specific functions. For example, for ...
As part of the settlement, Moderna will pay Arbutus and Genevant $950 million upfront in July 2026 ("Noncontingent Settlement ...
Asteroid Ryugu appears to contain all the necessary ingredients to make the DNA and RNA underpinning life on Earth.
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results